Efficacy + Safety Of Palbociclib (P) In Patients (Pts) <= 50 Y With Hormone Receptor-Positive (Hr+)/Human Epidermal Growth Factor Receptor 2-Negative (Her2-) Advanced Breast Cancer (Abc): Subgroup Analysis Of 2 Randomized Phase 3 Studies (Vol 41s1, Pg S11, 2018)

BREAST(2020)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要